Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-05-16
2006-05-16
Andres, Janet L. (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S351000, C424S085200
Reexamination Certificate
active
07045498
ABSTRACT:
Novel polypeptide combinations, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed for soluble zcytor11 receptors that may be used as novel cytokine antagonists, and within methods for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo. Ligand-binding receptor polypeptides and antibodies can also be used to block TIF activity in vitro and in vivo, and may be used in conjunction with TIF and other cytokines to selectively stimulate the immune system. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto.
REFERENCES:
patent: 5965704 (1999-10-01), Lok et al.
patent: 99/07848 (1999-02-01), None
patent: 00/39161 (2000-06-01), None
patent: 01/16318 (2001-08-01), None
patent: 02/072607 (2002-09-01), None
Xie, M-H et al.,J. Biol. Chem.275:31335-31339, 2000.
Kotenko, SV et al.,J. Immunol.166:7096-7013, 2001.
Kotenko, SV et al.,J. Biol. Chem.276:2725-2732, 2001.
Kotenko, SV et al.,Oncogene,19:2557-2565, 2000.
Zhang, et al.,J. Biol. Chem,272:9474-9480, 1997.
Blumberg, H. et al.,Cell 104:9-19, 2001.
Xu. W. et al.,Proc. Nat. Acad. Sci.98:9511-9516, 2001 (pub. online Jul. 31, 2001).
Liu et al.,Journal of Immunology152:1821-1829, 1994.
Dumoutier, L. et al.,Journal of Immunology164: 1814-1819, 2000.
Dumoutier, L. et al.,Proc. Nat. Acad. Sci. 97:10144-10149, 2000.
Dumoutier, L. et al.,J. Immunol. 166:7090-7095, 2001.
Dumoutier, L. et al.,J. Immunol. 167:3545-3549, 2001.
GenBank Accession No. T70439, 1995.
GenBank Accession No. T70354, 1995.
GenBank Accession No. AA132964, 1995.
Kindsvogel Wayne R.
Topouzis Stavros
Andres Janet L.
Hamud Fozia
Johnson Jennifer K.
ZymoGenetics Inc.
LandOfFree
Soluble Zcytor11 cytokine receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Soluble Zcytor11 cytokine receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Soluble Zcytor11 cytokine receptors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3595428